Experimental Hematology
Volume 30, Issue 10 , Pages 1139-1146 , October 2002

Induction of apoptosis in K562 cells by dominant negative c-myb

  • Ho Keun Yi

      Affiliations

    • Department of Pediatrics, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Sang Yun Nam

      Affiliations

    • Department of Biology, College of Science and Technology, Jeonju University, Jeonju, South Korea
    • ,
  • Jae Cheol Kim

      Affiliations

    • Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Jung Soo Kim

      Affiliations

    • Department of Pediatrics, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Dae Yeol Lee

      Affiliations

    • Department of Pediatrics, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, South Korea
    • ,
  • Pyoung Han Hwang

      Affiliations

    • Corresponding Author InformationOffprint requests to: Pyoung Han Hwang M.D., Ph.D., Department of Pediatrics, Chonbuk National University, Medical School, Jeonju, Jeonbuk, 561-712, South Korea
    • Department of Pediatrics, Chonbuk National University Medical School, Jeonju, South Korea
    • Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, South Korea

Received 23 January 2002 ,Revised 10 May 2002 ,Accepted 10 June 2002.

References 

  1. Luscher B, Eisenman RN. New light on Myc and Myb. Genes Dev. 1990;4:2025
  2. Sakura H, Kanei-Ishii C, Nagase T, et al.  Delineation of three functional domains of the transcription activator encoded by the c-myb protooncogene. Proc Natl Acad Sci USA. 1989;89:3088
  3. Duprey SP, Boettinger D. Developmental regulation of c-myb in normal myeloid progenitor cells. Proc Natl Acad Sci USA. 1985;82:6937
  4. Barletta C, Pelicci PG, Kenyon LC, Smith SD, Dalla-Favera R. Relationship between the c-myb locus and the 6q-chromosome aberration in leukemia and lymphoma. Science. 1987;235:1064
  5. Gewirtz AM, Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science. 1988;242:1303
  6. Gewirtz AM. Oligodeoxynucleotide-based therapeutics for human leukemia. Stem Cells. 1993;11(suppl. 3):96
  7. Gewirtz AM. Myb targeted therapeutics for the treatment of human malignancies. Oncogene. 1999;18:3056
  8. Ho PT, Parkinson DR. Antisense oligonucleotides as therapeutics for malignant diseases. Semin Oncol. 1997;24:187
  9. Seto M, Jaeger U, Hockett RD, et al.  Alternative promoters and exons, somatic mutation and deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J. 1988;7:123
  10. Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B cell activation and rescue from apoptosis. Mol Cell Biol. 1996;16:5546
  11. Takeuchi M, Shichinohe T, Senmaru N, et al.  The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice. Gene Ther. 2000;7:518
  12. Niu G, Heller R, Catlett-Falcone R, et al.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 1999;59:5059
  13. Sun L, Heerema N, Crotty L, et al.  Expression of dominant negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 1999;96:680
  14. Watts RG, Huang C, Young MR, et al.  Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 1998;17:3493
  15. Wolff L, Schmidt M, Koller R, et al.  Three genes with different functions in transformation are regulated by c-Myb in myeloid cells. Blood Cells Mol Dis. 2001;27:483
  16. Dooley S, Seib T, Welter C, Blin N. c-myb intron 1 protein binding and association with transcriptional activity in leukemic cells. Leuk Res. 1996;20:429
  17. Raitano AB, Halpern JR, Hambuch TM, Sawyers CL. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci U S A. 1995;92:11746
  18. Fernandez-Luna JL. Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells. Apoptosis. 2000;5:315
  19. Oliver FJ, de la Rubia G, Rolli V, et al.  Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. J Biol Chem. 1998;273:33533
  20. Tesch H, Michels M, Jucker M, et al.  Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis. Leuk Res. 1992;16:265
  21. Hijiya N, Gewirtz AM. Oncogenes, protooncogenes, and tumor suppressor genes in acute myelogenous leukemia. J Pediatr Hematol Oncol. 1995;17:101
  22. Tomita A, Watanabe T, Kosugi H, et al.  Truncated c-Myb expression in the human leukemia cell line TK-6. Leukemia. 1998;12:1422
  23. Amaravadi L, King MW. Characterization and expression of the Xenopus c-Myb homolog. Oncogene. 1994;9:971
  24. Ramsay RG, Thompson MA, Hayman JA, et al.  Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ. 1992;3:723
  25. Lipsick JS. One billion years of Myb. Oncogene. 1996;13:223
  26. Dai P, Akimaru H, Tanaka Y, et al.  CBP as a transcriptional coactivation of c-myb. Genes Dev. 1996;10:528
  27. Frampton J, Ramqvist T, Graf T. v-myb of E26 leukemia virus up-regulate bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev. 1996;10:2720
  28. Qin JZ, Zhang CL, Kamarashev J, et al.  Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood. 2001;98:2778
  29. Schmidt M, Koller R, Haviernik P, et al.  Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation. Oncogene. 2001;20:6205
  30. Taylor D, Badiani P, Weston K. A dominant interfering Myb mutant cause apoptosis in T cells. Genes Dev. 1996;10:2732
  31. Thompson MA, Rosenthal MA, Ellis SL, et al. (19 9 8) c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased bcl-2 expression. Cancer Res 58:5168
  32. Zorbas M, Sicurella C, Bertoncello I, et al.  c-myb is critical for murine colon development. Oncogene. 1999;18:5821
  33. Bies J, Wolff L. Oncogenic activation of c-myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene. 1997;14:203
  34. Gonda TJ. The c-myb oncoprotein. Int J Biochem Cell Biol. 1998;30:547

PII: S0301-472X(02)00896-2

Experimental Hematology
Volume 30, Issue 10 , Pages 1139-1146 , October 2002

Article Tools

* Image Usage & Resolution